We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLSS icon
5801
Milestone Scientific
MLSS
$35.3M
$23K ﹤0.01%
11,838
+10,838
+1,084% +$19.8K
MRKR icon
5802
Marker Therapeutics
MRKR
$18.8M
$23K ﹤0.01%
1,098
+452
+70% +$9.88K
NLR icon
5803
VanEck Uranium + Nuclear Energy ETF
NLR
$3.82B
$23K ﹤0.01%
532
-56
-10% -$2.4K
ORMP icon
5804
Oramed Pharmaceuticals
ORMP
$167M
$23K ﹤0.01%
6,595
+159
+2% +$534
XIN
5805
DELISTED
Xinyuan Real Estate
XIN
$23K ﹤0.01%
1,062
-730
-41% -$17.9K
ASHX
5806
DELISTED
Xtrackers MSCI China A Inclusion Equity ETF
ASHX
$23K ﹤0.01%
1,044
ACRS icon
5807
Aclaris Therapeutics
ACRS
$726M
$22K ﹤0.01%
13,546
+9,724
+254% +$13K
BNR
5808
Burning Rock Biotech
BNR
$93.9M
$22K ﹤0.01%
+81
New +$22.2K
CRESY
5809
Cresud
CRESY
$795M
$22K ﹤0.01%
7,965
-3,647
-31% -$11.7K
DWSH icon
5810
AdvisorShares Dorsey Wright Short ETF
DWSH
$6.44M
$22K ﹤0.01%
+1,112
New +$27.7K
LOAN
5811
Manhattan Bridge Capital
LOAN
$47.5M
$22K ﹤0.01%
4,660
YANG icon
5812
Direxion Daily FTSE China Bear 3X ETF
YANG
$82.6M
$22K ﹤0.01%
33
-718
-96% -$542K
CHAD
5813
DELISTED
Direxion Daily CSI 300 China A Share Bear 1X Shares
CHAD
$22K ﹤0.01%
877
CFMS
5814
DELISTED
Conformis, Inc. Common Stock
CFMS
$22K ﹤0.01%
1,055
+495
+88% +$10.3K
EGIF
5815
DELISTED
Eagle Growth and Income Opportunities Fund
EGIF
$22K ﹤0.01%
1,611
NAV.PRD
5816
DELISTED
Navistar International Corporation Cumulative Convertible Junior Preference Stock, Series D
NAV.PRD
$22K ﹤0.01%
1,010
+1,000
+10,000% +$21.3K
GFN
5817
DELISTED
General Finance Corporation
GFN
$22K ﹤0.01%
3,243
+2,345
+261% +$14.2K
EVOL
5818
DELISTED
Evolving Systems, Inc.
EVOL
$22K ﹤0.01%
20,085
BZQ icon
5819
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.32M
$21K ﹤0.01%
75
+43
+134% +$17.7K
DBAW icon
5820
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$287M
$21K ﹤0.01%
798
-1,846
-70% -$46.5K
FDLO icon
5821
Fidelity Low Volatility Factor ETF
FDLO
$1.44B
$21K ﹤0.01%
563
-20
-3% -$701
FET icon
5822
Forum Energy Technologies
FET
$708M
$21K ﹤0.01%
2,031
+1,444
+246% +$11.6K
CYPH
5823
Cypherpunk Technologies Inc
CYPH
$62.9M
$21K ﹤0.01%
1,001
+1,000
+100,000% +$21.4K
RDHL
5824
Redhill Biopharma
RDHL
$3.95M
$21K ﹤0.01%
3
-2
-40% -$13.8K
LNAI
5825
Lunai Bioworks
LNAI
$8.8M
$21K ﹤0.01%
61
+38
+165% +$11.5K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.